Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation

OBJECTIVES: Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants, and there is no vaccine available. In early life, the most important contributors to protection against infectious diseases are the innate immune response and maternal antibodies....

Descripción completa

Detalles Bibliográficos
Autores principales: van Erp, Elisabeth A, Lakerveld, Anke J, de Graaf, Erik, Larsen, Mads D, Schepp, Rutger M, Hipgrave Ederveen, Agnes L, Ahout, Inge ML, de Haan, Cornelis AM, Wuhrer, Manfred, Luytjes, Willem, Ferwerda, Gerben, Vidarsson, Gestur, van Kasteren, Puck B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029726/
https://www.ncbi.nlm.nih.gov/pubmed/32099650
http://dx.doi.org/10.1002/cti2.1112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029726/
https://www.ncbi.nlm.nih.gov/pubmed/32099650
http://dx.doi.org/10.1002/cti2.1112

Ejemplares similares